Diagnostic News and Research

RSS

Study: 10 to 15% of people with TIAs will experience strokes within three months

Each year, as many as 500,000 Americans experience mini strokes called transient ischemic attacks (TIAs). Symptoms quickly go away, usually within an hour, and many people don't seek treatment. But 10 to 15 percent of people who experience TIAs will experience full-blown strokes within three months, and 40 percent of these strokes will occur in the first 24 hours, according to an article by three Loyola University Medical Center neurologists in the journal Expert Review of Neurotherapeutics.

6 Feb 2013

ASM to host 2013 Biodefense and Emerging Diseases Research Meeting from Feb. 25-27

The American Society for Microbiology (ASM) will host its 2013 Biodefense and Emerging Diseases Research Meeting February 25-27, 2013 at the Marriott Wardman Park Hotel in Washington, DC.

6 Feb 2013

Viracor-IBT Laboratories signs definitive agreement to purchase assets of Cylex

Viracor-IBT Laboratories, Inc. announced today that it has signed a definitive agreement to purchase the assets of Cylex, Inc., a global life sciences company focused on the development, manufacturing and commercialization of in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine.

5 Feb 2013

NSU-COM to hold grand opening for America's first Institute for Neuro Immune Medicine

Nova Southeastern University's College of Osteopathic Medicine (NSU-COM) will hold a grand opening for America's first Institute for Neuro Immune Medicine on Feb. 12.

5 Feb 2013

Maimonides, Navidea to evaluate Lymphoseek use in lymphatic mapping for colorectal cancer

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced it has entered into an agreement to collaborate with Maimonides Medical Center to investigate the utility of Lymphoseek (technetium Tc 99m tilmanocept) Injection in lymphatic mapping procedures for colorectal cancer.

5 Feb 2013

Luminex consolidated fourth quarter revenue increases 16% to $55.5 million

Luminex Corporation today announced financial results for the fourth quarter and year ended December 31, 2012.

From Luminex 4 Feb 2013

COPD underdiagnosed in Chinese lung cancer patients

Chronic obstructive pulmonary disease is underdiagnosed and undertreated among lung cancer patients in China, study results show.

4 Feb 2013

Sleep disorders common in active duty military personnel

Researchers have found significant associations between service-related illnesses and a high rate of sleep disorders, particularly insomnia, in US military personnel.

4 Feb 2013

Delirium overlooked in hospital patients

Delirium occurs in about one in five inpatients, but appears to be a low priority with hospital staff, research suggests.

4 Feb 2013

New method for detecting cancer by measuring elasticity of tumours

As the first countries in the world, Norway and France will be testing a completely new method for detecting cancer. This is done by measuring the elasticity of tumours. The method is called elastography. You may as well learn this new word right away; in a few years, elastography may be as common as X-rays.

4 Feb 2013

Scientists receive honorary doctorate for research on Alzheimer's disease

On Monday 4 February, Dennis J. Selkoe and five other "brain teasers" will receive an honorary doctorate from the KU Leuven. The promoters for this honorary doctorate - VIB-KU Leuven professors Bart De Strooper and Wim Robberecht - will honor Dennis J. Selkoe for his scientific insights, but also for his relentless search for new medicines to treat Alzheimer's Disease and other conditions that cause severe damage in the brain.

4 Feb 2013

Investigators use genome analysis to eliminate lifetime drug prescription in two children

Using genome-wide analysis, investigators at the Sainte-Justine University Hospital Research Center and the University of Montreal have potentially eliminated a lifetime drug prescription that two children with a previously unknown type of adrenal insufficiency had been receiving for 14 years.

4 Feb 2013

Potential connection between autism and insulin-like growth factor

A New York-based physician-researcher from Touro College of Osteopathic Medicine, best known for his research into fertility and twinning, has uncovered a potential connection between autism and a specific growth protein that could eventually be used as a way to predict an infant's propensity to later develop the disease.

2 Feb 2013

CBT and graded exercise therapy increase likelihood of recovery from chronic fatigue syndrome

Research led by Queen Mary, University of London, has shown that recovery from chronic fatigue syndrome (CFS) is possible for some patients, and has identified two treatments most likely to lead to recovery.

2 Feb 2013

Researchers determine differences in stiffness between healthy and cancerous tissue

The texture of breast cancer tissue differs from that of healthy tissue. Using a cutting-edge tissue diagnostic device, a group of researchers in Basel, Switzerland, has determined one key difference: cancerous tissue is a mix of stiff and soft zones, whereas healthy tissue has uniform stiffness.

2 Feb 2013

Cedars-Sinai healthcare professionals to mark National Wear Red Day

Hundreds of healthcare professionals at the Cedars-Sinai Heart Institute will wear red on Friday, Feb. 1, to mark National Wear Red Day. A few hours later, the new Cedars-Sinai Advanced Health Sciences Pavilion will be lit with a projection of the red dress symbol that represents a public education program to boost women's awareness of heart disease.

1 Feb 2013

New CT system reduces radiation exposure in patients undergoing CCTA

Researchers using a newly approved advanced computed tomography (CT) system were able to significantly reduce radiation exposure in patients undergoing coronary CT angiography (CCTA), according to a new study published online in the journal Radiology.

1 Feb 2013

Resonance Health receives FDA marketing authorization for FerriScan R2-MRI device

The U.S. Food and Drug Administration recently announced the authorization of FerriScan R2-MRI to be marketed as an imaging companion diagnostic device for the safe and effective use of Exjade in patients with non-transfusion-dependent thalassemia.

31 Jan 2013

Strong placebo response key to adolescent migraine trial failures

A strong response to placebo is the main reason drug trials in the treatment of adolescent migraine have so far failed, say researchers.

31 Jan 2013

TB test offers rapid detection of TB and drug-resistant strains according to new study

A diagnostic test for tuberculosis (TB) can accurately and quickly detect both TB and drug-resistant strains, according to a new study. The authors of a new systematic review assessing the diagnostic accuracy of the Xpert® MTB/RIF test published in The Cochrane Library say their study can provide timely advice for clinicians and policymakers in countries where TB is a major public health problem.

31 Jan 2013

Diagnostic News and Research

Study: 10 to 15% of people with TIAs will experience strokes within three months

ASM to host 2013 Biodefense and Emerging Diseases Research Meeting from Feb. 25-27

Viracor-IBT Laboratories signs definitive agreement to purchase assets of Cylex

NSU-COM to hold grand opening for America's first Institute for Neuro Immune Medicine

Maimonides, Navidea to evaluate Lymphoseek use in lymphatic mapping for colorectal cancer

Luminex consolidated fourth quarter revenue increases 16% to $55.5 million

COPD underdiagnosed in Chinese lung cancer patients

Sleep disorders common in active duty military personnel

Delirium overlooked in hospital patients

New method for detecting cancer by measuring elasticity of tumours

Scientists receive honorary doctorate for research on Alzheimer's disease

Investigators use genome analysis to eliminate lifetime drug prescription in two children

Potential connection between autism and insulin-like growth factor

CBT and graded exercise therapy increase likelihood of recovery from chronic fatigue syndrome

Researchers determine differences in stiffness between healthy and cancerous tissue

Cedars-Sinai healthcare professionals to mark National Wear Red Day

New CT system reduces radiation exposure in patients undergoing CCTA

Resonance Health receives FDA marketing authorization for FerriScan R2-MRI device

Strong placebo response key to adolescent migraine trial failures

TB test offers rapid detection of TB and drug-resistant strains according to new study

Industry Focus eBook - Cell biology (5th edition) eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News